Skip to main content
logo
Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.0320
-0.0036 (-10.11%)
At close: Oct 1, 2026

Nymox Pharmaceutical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-3.68-3.68-4.28-8.35-6.65-12.5
Net Income
-4.28-4.28-4.49-8.84-6.58-12.54
Earnings Per Share
-0.04-0.04-0.05-0.10-0.07-0.15
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.010.010.070.071.40.83
Total Debt
5.835.833.530.750.170.39
Net Cash (Debt)
-5.82-5.82-3.46-0.681.230.44
Net Cash Growth
----180.18%-86.22%
Net Cash Per Share
-0.06-0.06-0.04-0.010.010.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1.81-1.81-2.6-4.06-5.21-9.82
Capital Expenditures
-0-0--0--0.01
Free Cash Flow
-1.81-1.81-2.6-4.06-5.21-9.83
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------